Hong Yang

8PUBLICATIONS
12CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 11, 2026
Sintilimab plus cisplatin and nab-paclitaxel induction treatment for locally advanced borderline-resectable oesophageal squamous cell carcinoma: A single-arm, prospective, phase 2 study (NEOCRTEC2001).

|Feb 12, 2026
Fibrin sealant for prophylaxis of cervical anastomotic leakage after McKeown esophagectomy for esophageal or esophagogastric junction cancer (PLACE030): a Phase III multicenter randomized clinical trial.

Zhichao Li, Geng Wang, Teng Mao

|Jan 12, 2026
Serum cytokines predict response and survival in esophageal squamous cell carcinoma receiving chemoradiotherapy combined with anti-PD-1 antibody: analyses of two phase II clinical trials.

BaoQing Chen, Junying Chen, Sifen Wang

|Dec 19, 2025
Integrating lymphovascular invasion and ypTNM staging system for esophageal squamous cell carcinoma undergoing neoadjuvant chemoradiotherapy and surgery: a multi-institutional analysis.

Shiliang Liu, Yujin Xu, Xufeng Guo

|Sep 17, 2025
Circulating tumor DNA as a marker of molecular residual disease in resected esophageal squamous cell carcinoma.

Cai-Yan Fang, Jing Wen, Jia-Di Wu

|Jun 09, 2025
Proteomics analysis and immune profiling reveal regulators of PD-L1 in oesophageal squamous cell carcinoma.

Yuying Li, Xiaoyi Yuan, Xing-Feng Yin

Pageof 2

Frequent Collaborators

3 joint publications

Baoqing Chen

3 joint publications

Qiaoqiao Li

3 joint publications

Mian Xi

2 joint publications

Shiliang Liu